Viveve Medical, Inc. (VIVE) Financial Statements (2025 and earlier)

Company Profile

Business Address 345 INVERNESS DRIVE SOUTH
ENGLEWOOD, CO 80112
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,43114,04519,16222,66525,39128,446
Cash and cash equivalents9,43114,04519,16222,66525,39128,446
Receivables801509549514696336
Inventory, net of allowances, customer advances and progress billings1,5991,5521,4722,1502,6323,049
Inventory1,5991,5521,4722,1502,6323,049
Other undisclosed current assets1,4071,3931,0552,0831,9882,043
Total current assets:13,23817,49922,23827,41230,70733,874
Noncurrent Assets
Property, plant and equipment1,1141,3511,5541,6781,9592,316
Long-term investments and receivables  455577645678757
Long-term investments  455577645678757
Other noncurrent assets1,1361,3791,544649684723
Total noncurrent assets:2,2503,1853,6752,9723,3213,796
TOTAL ASSETS:15,48820,68425,91330,38434,02837,670
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,2066,5144,5333,8492,9543,030
Interest and dividends payable1,102980    
Employee-related liabilities545556    
Accounts payable9041,6021,4801,2926621,157
Accrued liabilities3,6553,3763,0532,5572,2921,873
Debt5,4535,285   1,246
Other undisclosed current liabilities(1,647)(1,536)    
Total current liabilities:10,01210,2634,5333,8492,9544,276
Noncurrent Liabilities
Long-term debt and lease obligation   5,1244,9644,8094,757
Long-term debt, excluding current maturities   5,1244,9644,8094,757
Liabilities, other than long-term debt2002651,1901,2061,1501,097
Other liabilities2002651,1901,2061,1501,097
Total noncurrent liabilities:2002656,3146,1705,9595,854
Total liabilities:10,21210,52810,84710,0198,91310,130
Equity
Equity, attributable to parent, including:5,27610,15615,06620,36525,11527,540
Common stock 11111
Additional paid in capital258,813257,894256,918255,889254,781253,156
Accumulated deficit(253,538)(247,739)(241,853)(235,525)(229,667)(225,617)
Other undisclosed equity, attributable to parent 1     
Total equity:5,27610,15615,06620,36525,11527,540
TOTAL LIABILITIES AND EQUITY:15,48820,68425,91330,38434,02837,670

Income Statement (P&L) ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Revenues1,7951,6411,7061,6161,6541,450
Cost of revenue
(Cost of Goods and Services Sold)
(1,501)(1,321)(1,747)(1,502)(1,489)(1,068)
Gross profit:294320(41)114165382
Operating expenses(5,314)(5,793)(5,946)(5,606)(5,110)(5,511)
Operating loss:(5,020)(5,473)(5,987)(5,492)(4,945)(5,129)
Nonoperating expense
(Other Nonoperating expense)
(40)(21)(7)(78)(53)(65)
Interest and debt expense(284)(270)(266)(255)1,113(234)
Other undisclosed loss from continuing operations before equity method investments, income taxes     (86)(287)
Loss from continuing operations before equity method investments, income taxes:(5,344)(5,764)(6,260)(5,825)(3,971)(5,715)
Loss from equity method investments  (122)(68)(33)(79)(76)
Loss from continuing operations:(5,344)(5,886)(6,328)(5,858)(4,050)(5,791)
Loss before gain (loss) on sale of properties:(5,344)(5,886)(6,328)(5,858)(4,050)(5,791)
Net loss:(5,344)(5,886)(6,328)(5,858)(4,050)(5,791)
Other undisclosed net loss attributable to parent (455)     
Net loss attributable to parent:(5,799)(5,886)(6,328)(5,858)(4,050)(5,791)
Preferred stock dividends and other adjustments(1,305)(1,266)(1,228)(1,190)(1,119)(1,119)
Net loss available to common stockholders, diluted:(7,104)(7,152)(7,556)(7,048)(5,169)(6,910)

Comprehensive Income ($ in thousands)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
Net loss:(5,344)(5,886)(6,328)(5,858)(4,050)(5,791)
Comprehensive loss, net of tax, attributable to parent:(5,344)(5,886)(6,328)(5,858)(4,050)(5,791)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: